Similar articles for PMID: 31430249

Year	Number of Results
1998	3
1999	2
2000	2
2001	2
2002	4
2003	4
2004	2
2005	3
2006	8
2007	10
2008	9
2009	13
2010	10
2011	6
2012	7
2013	7
2014	2
2015	1
2016	2
2017	4
2018	7
2019	6
2020	10
2021	14
2022	10
2023	6
2024	0

1

Limited Sampling Strategy for the Estimation of Mycophenolic Acid and its Acyl Glucuronide Metabolite Area under the Concentration-Time Curve in Japanese Lung Transplant Recipients.

Tanaka M, Kikuchi M, Takasaki S, Hirasawa T, Sigeta K, Noda A, Akiba M, Matsuda Y, Oishi H, Sado T, Noda M, Okada Y, Mano N, Yamaguchi H. Tanaka M, et al. J Pharm Pharm Sci. 2019;22(1):407-417. doi: 10.18433/jpps30505. J Pharm Pharm Sci. 2019. PMID: 31430249 Free article.

2

Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.

Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH. Ting LS, et al. Ther Drug Monit. 2008 Jun;30(3):282-91. doi: 10.1097/FTD.0b013e318166eba0. Ther Drug Monit. 2008. PMID: 18520599

3

Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.

Pawinski T, Luszczynska P, Durlik M, Majchrzak J, Baczkowska T, Chrzanowska M, Sobiak J, Glyda M, Kuriata-Kordek M, Kamińska D, Krajewska M, Klinger M. Pawinski T, et al. Ther Drug Monit. 2013 Dec;35(6):760-9. doi: 10.1097/FTD.0b013e31829b88f5. Ther Drug Monit. 2013. PMID: 24192641

4

Limited sampling strategy for the estimation of mycophenolic acid area under the curve in Tunisian renal transplant patients.

Gaies E, Ben Sassi M, El Jebari H, Jebabli N, Charfi R, Chokri I, Salouage I, Klouz A, Trabelsi S. Gaies E, et al. Nephrol Ther. 2017 Nov;13(6):460-462. doi: 10.1016/j.nephro.2017.02.010. Epub 2017 Sep 22. Nephrol Ther. 2017. PMID: 28958670

5

Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.

Beckebaum S, Armstrong VW, Cicinnati VR, Streit F, Klein CG, Gerken G, Paul A, Oellerich M. Beckebaum S, et al. Ther Drug Monit. 2009 Apr;31(2):205-10. doi: 10.1097/FTD.0b013e31819743d9. Ther Drug Monit. 2009. PMID: 19307937 Clinical Trial.

6

Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.

Shipkova M, Armstrong VW, Weber L, Niedmann PD, Wieland E, Haley J, Tönshoff B, Oellerich M; German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. Shipkova M, et al. Ther Drug Monit. 2002 Jun;24(3):390-9. doi: 10.1097/00007691-200206000-00011. Ther Drug Monit. 2002. PMID: 12021631 Clinical Trial.

7

Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipients.

Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH. Ting LS, et al. Ann Pharmacother. 2006 Sep;40(9):1509-16. doi: 10.1345/aph.1H149. Epub 2006 Aug 1. Ann Pharmacother. 2006. PMID: 16882870 Clinical Trial.

8

Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.

Miura M, Satoh S, Niioka T, Kagaya H, Saito M, Hayakari M, Habuchi T, Suzuki T. Miura M, et al. Ther Drug Monit. 2008 Feb;30(1):52-9. doi: 10.1097/FTD.0b013e31815f5416. Ther Drug Monit. 2008. PMID: 18223463 Clinical Trial.

9

No Influence of Everolimus on Mycophenolic Acid Area Under the Concentration-Time Curve: Limited Sampling Strategy for Mycophenolic Acid in Japanese Kidney Transplant Recipients Treated With Tacrolimus, Mycophenolate Mofetil, Steroid, and Everolimus.

Endo T, Ishimura T, Nishioka S, Yokoyama N, Ogawa S, Fujisawa M. Endo T, et al. Transplant Proc. 2022 Mar;54(2):286-292. doi: 10.1016/j.transproceed.2021.08.066. Epub 2022 Jan 13. Transplant Proc. 2022. PMID: 35034789

10

Pharmacogenetic impact of UDP-glucuronosyltransferase metabolic pathway and multidrug resistance-associated protein 2 transport pathway on mycophenolic acid in thoracic transplant recipients: an exploratory study.

Ting LS, Benoit-Biancamano MO, Bernard O, Riggs KW, Guillemette C, Ensom MH. Ting LS, et al. Pharmacotherapy. 2010 Nov;30(11):1097-108. doi: 10.1592/phco.30.11.1097. Pharmacotherapy. 2010. PMID: 20973683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

140 results

Results by year